Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

Diabetes

Aliases
Diabetes Mellitus

128 clinical trials

126 products

7 drugs

Clinical trial
A 12-months Multi-national, Multi-centre, Double Blind, Randomised, Parallel Safety and Efficacy Comparison of Insulin Detemir Produced by the Current Process and Insulin Detemir Produced by the NN729 Process in Subjects With Type 1 Diabetes on a Basal-bolus Regimen With Insulin Aspart as the Bolus Insulin
Status: Completed, Estimated PCD: 2008-07-01
Product
Insulin Aspart
Product
Insulin Detemir
Clinical trial
Efficacy of Glycaemic Control of Biphasic Insulin Aspart (NovoMix® 30) or Insulin Detemir (Levemir®) in Patients With Type 1 or 2 Diabetes Mellitus
Status: Completed, Estimated PCD: 2008-09-01
Product
Biphasic Insulin Aspart 30
Product
Insulin NPH
Clinical trial
Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
Status: Completed, Estimated PCD: 2007-08-01
Clinical trial
A Randomized, Single-blind, Single-centre, Two-period, Cross-over Trial Investigating the Bioequivalence Between Completed Phase 2 and Planned Phase 3 Formulations of Liraglutide in Healthy Subjects
Status: Completed, Estimated PCD: 2004-06-30
Product
liraglutide
Clinical trial
A Single Center, Randomized, Double-Blind, 2-period, 2-sequence Crossover Designed Study to Evaluate the Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject
Status: Completed, Estimated PCD: 2023-10-26
Product
HR011408
Clinical trial
A 20-week, Multi-centre, Open-labelled, Non-comparative Evaluation of the Safety and Efficacy of Insulin Detemir in Combination With Oral Anti-diabetic Drug(s), in Subjects With Type 2 Diabetes Mellitus Who Were Inadequately Controlled on Current Therapy in Korea
Status: Completed, Estimated PCD: 2008-10-01
Clinical trial
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
Status: Recruiting, Estimated PCD: 2024-09-30
Product
Placebo
Product
Adezunap
Clinical trial
Effect of NNC 90-1170 on Hypoglycaemic Counterregulation During Stepwise Hypoglycaemic Clamp in Type 2 Diabetic Subjects. A Double-blind, Placebo-controlled, Randomised, 2-period Cross-over Trial
Status: Completed, Estimated PCD: 2001-11-01
Product
placebo
Product
NovoRapid HR011408
Product
NovoRapid
Product
HR011408 injection
Clinical trial
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Status: Active (not recruiting), Estimated PCD: 2024-04-15
Product
Insulin Degludec
Product
Insulin Efsitora Alfa
Clinical trial
Comparing Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Subjects With Diabetics- A Randomized, Double-Blind, Three-cycle Crossover Phase I Clinical Trial
Status: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
Status: Active (not recruiting), Estimated PCD: 2024-05-06
Clinical trial
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Phase 1 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Cotadutide in Chinese Overweight/Obese Subjects With Type 2 Diabetes Mellitus
Status: Completed, Estimated PCD: 2022-12-12
Clinical trial
A Multi-center, Randomized, Open-label, Parallel-group, Phase Ⅲ Study to Evaluate the Efficacy and Safety of Insulin Aspart Injection in Patients With Diabetes Mellitus Compared to NovoRapid®
Status: Completed, Estimated PCD: 2016-08-12
Product
INS062
Clinical trial
Bioequivalence Studyof INS062 Injection and NovoRapid ®in Healthy Subjects and Pharmacokinetics and Pharmacodynamics Study of Single Subcutaneous Injection of HR20014 in Healthy Subjects
Status: Recruiting, Estimated PCD: 2023-07-01
Product
Cotadutide
Clinical trial
Open-label, Single-dose Study of Polysaccharide Superparamagnetic Iron Oxide Injection for Contrast-enhanced Cardiovascular Magnetic Resonance Imaging in Patients With Type 2 Diabetes and Chronic Kidney Disease.
Status: Completed, Estimated PCD: 2022-06-13
Product
DERMASEAL
Product
Plasma
Clinical trial
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Study to Assess the Safety of DERMASEAL Advanced Wound Care Dressing for the Treatment of Chronic Non-healing, Neuropathic Diabetic Foot Ulcers
Status: Recruiting, Estimated PCD: 2023-09-30
Product
Insulin Degludec and Insulin Aspart
Product
RO 205-2349
Clinical trial
A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients With Concomitant Peripheral Arterial Disease (PAD)
Status: Terminated, Estimated PCD: 2019-09-24
Product
HR20014
Clinical trial
A Phase II Randomized, Double-Blind, Dose-Ranging Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
Status: Completed, Estimated PCD: 2004-03-01
Product
Polysaccharide superparamagnetic iron oxide
Product
Insulin Aspart 30
Product
Hydrochlorothiazide
Clinical trial
Evaluation of Drug-drug Interaction Between Henagliflozin Proline and Hydrochlorothiazide in Healthy Chinese Volunteers
Status: Completed, Estimated PCD: 2019-10-10
Product
Engensis
Clinical trial
A Multi-center, Randomized, Open, Phase III Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared Efficacy and Safety With Insulin Degludec/Insulin Aspart(Ryzodeg) in Chinese Subjects With Type 2 Diabetes
Status: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Status: Completed, Estimated PCD: 2019-06-14
Product
Insulin degludec
Product
Insulin degludec + Liraglutide
Product
Alpha-Lipoic Acid
Product
Insulin detemir
Clinical trial
A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes
Status: Completed, Estimated PCD: 2020-12-17
Clinical trial
Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes
Status: Completed, Estimated PCD: 2006-12-01
Product
LX9211
Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of LX9211 in the Treatment of Diabetic Peripheral Neuropathic Pain
Status: Completed, Estimated PCD: 2022-05-23
Clinical trial
An Observational, Safety and Efficacy Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus.
Status: Completed, Estimated PCD: 2009-02-01
Clinical trial
A Multicenter, Interventional, Two-arm, Parallel-group, Randomized, Double-blinded, Placebo-controlled, Phase IV Trial to Evaluate the Efficacy of Alpha-Lipoic Acid in the Treatment of Symptomatic Diabetic Polyneuropathy in Egypt
Status: Recruiting, Estimated PCD: 2024-04-01
Product
Dalbavancin
Product
Liraglutide
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Phase Ib Study in Overweight/Obese Subjects Without Diabetes to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of TG103 Injection
Status: Completed, Estimated PCD: 2022-12-01
Clinical trial
Retrospective Observational Study on Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections - DALBADIA Study
Status: Completed, Estimated PCD: 2022-05-31
Product
TG103
Product
PF-06882961
Clinical trial
A 12-WEEK, PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF PF-06882961 TITRATION IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH METFORMIN AND IN NON-DIABETIC ADULTS WITH OBESITY
Status: Completed, Estimated PCD: 2021-11-17
Product
Mydriatic Agent
Clinical trial
A Multicenter, Open Label, Nonrandomized, Non Interventional, Observational, Safety and Efficacy Study of NovoRapid™(Insulin Aspart) in Patients With Coexisting Diabetes and Kidney Disease in India. The NovoRapid™ Nephropathy Study
Status: Withdrawn, Estimated PCD: 2009-11-01
Clinical trial
An Assessment of the Impact of Performing Physical Exercise on the Maximum Plasma Glucose Decline in Subjects With Type 1 Diabetes Managed on a Basal Bolus Insulin Regimen: A Comparison of 3 Basal Insulin Treatments - Insulin Detemir, Insulin Glargine and NPH Insulin
Status: Completed, Estimated PCD: 2006-11-01
Product
Biphasic Insulin Aspart
Product
Biphasic Human Insulin
Clinical trial
NovoMix® 30 (Biphasic Insulin Aspart 70/30) Titrate-to-target: An Observational Study of the Efficacy of NovoMix® 30 in Subjects With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets on OADs
Status: Completed, Estimated PCD: 2006-07-01
Clinical trial
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
Status: Completed, Estimated PCD: 2023-03-31
Clinical trial
A Randomized, Double-blind, Active-controlled, Cross-over Study to Assess the Effect of the Sugar Substitute "ENSO 16" on Glucose Metabolism Parameters in Healthy Subjects
Status: Completed, Estimated PCD: 2022-06-14
Product
Glucose
Product
ENSO 16
Product
Insulin aspart
Product
Insulin Glargine
Clinical trial
Safety and Effect of Biphasic Insulin Aspart 50 Compared to Biphasic Human Insulin 50 in Patients With Type 2 Diabetes Mellitus.
Status: Completed, Estimated PCD: 2007-11-01
Clinical trial
Safety and Therapeutic Effect of Insulin Detemir in Taiwanese Patients With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets With OAD With/Without Once-daily NPH Insulin Treatment
Status: Completed, Estimated PCD: 2007-08-01
Clinical trial
Observational, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
Status: Completed, Estimated PCD: 2008-03-01
Clinical trial
A Trial Comparing the Pharmacodynamics and Pharmacokinetics of HR20014, INS068 and INS062 in Healthy Subjects
Status: Completed, Estimated PCD: 2023-07-18
Product
Retagliptin Phosphate
Clinical trial
Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes
Status: Completed, Estimated PCD: 2009-03-01
Product
insulin
Product
glibenclamide
Product
repaglinide
Clinical trial
An Observational Post-Marketing Safety Registry Of Patients Who Have Been Prescribed Sativex®
Status: Completed, Estimated PCD: 2015-01-01
Product
Sativex®
Clinical trial
Pharmacokinetics and Safety of SP2086 in Subjects With Mild and Moderate Liver Impairment and Normal Liver Function.
Status: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Clinical Trial to Study the Efficacy and Safety of Insulin Aspart Three Times Per Day Compared to Glibenclamide Once or Twice Daily in Type 2 Diabetes by Comparison of Ability to Control Blood Glucose
Status: Terminated, Estimated PCD: 2006-04-01
Clinical trial
REPAMET 2: Observational Study of the Switch From Metformin Monotherapy to Bitherapy With Metformin and Repaglinide
Status: Completed, Estimated PCD: 2009-03-01
Product
metformin
Clinical trial
NNC 90-1170 Mechanism of Action: A Single-centre, Randomised, Double-blind, Parallel-group, Placebo-controlled Trial Evaluating the Effect of NNC 90-1170 on Weight and Appetite in Obese Subjects With Type 2 Diabetes
Status: Completed, Estimated PCD: 2002-03-01
Clinical trial
A Randomised, Double-blind, Placebo-controlled, Dose-escalation, Parallel-group, Single and Multiple Dosing Trial of NN90-1170 in Healthy Volunteers and Patients With Type 2 Diabetes to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Status: Completed, Estimated PCD: 1999-11-01
Clinical trial
Efficacy and Safety of a Standard Titration Algorithm Coupled With a Conventional Dietary Intervention or Intensive Dietary Intervention Versus a Standard Titration Algorithm, Alone, in Patients With Type 2 Diabetes Initiating NovoLog® Mix 70/30 Therapy
Status: Completed, Estimated PCD: 2006-06-01
Clinical trial
The Effect of Insulin Detemir on Glucose Control in Ageing Subjects With Type 2 Diabetes.
Status: Terminated, Estimated PCD: 2008-12-01
Clinical trial
Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
Status: Completed, Estimated PCD: 2008-09-01
Clinical trial
Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of Persistent Organic Pollutants in Obese Female Patients - OBESE (OBesity, cholEStyramine, womEn)
Status: Recruiting, Estimated PCD: 2025-10-31
Product
Cholestyramine
Clinical trial
Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh Through mHealth and Decentralized Primary Care: The Dinajpur Study
Status: Recruiting, Estimated PCD: 2026-09-30
Product
Multicomponent Decentralized Care
Product
mHealth
Clinical trial
Cinnamon Trial-Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.
Status: Completed, Estimated PCD: 2019-04-26
Product
Water-soluble cinnamon extract
Clinical trial
A Cohort Study on Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control Using Traditional Chinese Medicine of Blood-activating and Stasis-dissolving Method
Status: Not yet recruiting, Estimated PCD: 2025-10-31
Product
Western medicine
Clinical trial
A Clinical Guideline-based Management of Type-2 Diabetes by Ayurvedic Practitioners in Nepal: a Feasibility Cluster Randomised Controlled Trial
Status: Completed, Estimated PCD: 2024-01-04
Product
Clinical Guideline based Management
Clinical trial
Effects of Remimazolam and Propofol on Heart Rate Variability in Type 2 Diabetes Patients During Anesthesia Induction
Status: Recruiting, Estimated PCD: 2024-11-30
Product
Remimazolam
Product
Propofol
Clinical trial
Investigating the Impact of Topical Insulin on Postoperative Wound Healing in Diabetic and Non-Diabetic Patients: A Randomized Controlled Trial
Status: Active (not recruiting), Estimated PCD: 2024-06-01
Product
Insulin
Product
Povidone-Iodine
Clinical trial
The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
Status: Recruiting, Estimated PCD: 2024-08-14
Product
Colchicine
Clinical trial
Combined Anti-VEGF Intravitreal Injections With Sustained Steroid Implantation for the Treatment of Diabetic Macular Oedema
Status: Withdrawn, Estimated PCD: 2022-09-01
Product
Iluvien
Product
Ranibizumab
Clinical trial
Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults With Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a Randomized, Open-label, Cross-over Trial
Status: Recruiting, Estimated PCD: 2026-06-30
Product
Dulaglutide
Clinical trial
Safety and Efficacy of Oral Semaglutide in Hyperglycaemic Patients After Renal Transplantation
Status: Not yet recruiting, Estimated PCD: 2026-04-01
Product
Semaglutide
Clinical trial
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
Status: Completed, Estimated PCD: 2016-10-21
Product
Alpha tocopherol
Clinical trial
Polyclonal Regulatory T Cell (PolyTreg) Immunotherapy in Islet Transplantation
Status: Active (not recruiting), Estimated PCD: 2022-08-04
Product
PolyTregs
Clinical trial
Comparison of Pharmacokinetic (PK) Levels Before and After Conversion From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus (LCPT) in Diabetic Transplant récipients
Status: Completed, Estimated PCD: 2023-11-07
Product
Tacrolimus
Clinical trial
Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications
Status: Recruiting, Estimated PCD: 2024-01-16
Product
Bio
Clinical trial
The Effect of Omega 3 Fatty Acids on Blood Glucose, Lipids Profile, Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
Status: Completed, Estimated PCD: 2020-05-01
Product
Glimepiride
Clinical trial
The Effect of an Extract of Green Tea on Glucose Control in Adults With Type 2 Diabetes
Status: Completed
Product
Green and Black Tea
Clinical trial
Glucocorticoid Effects in Patients With DM Type 2
Status: Completed, Estimated PCD: 2017-04-01
Product
Prednisone
Clinical trial
Endoscopic Sleeve Gastroplasty (ESG) Versus Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Versus ESG + GLP-1RA in Patients With Obesity, Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis: A Randomized Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2025-07-01
Product
GLP1-RA
Clinical trial
Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study
Status: Completed, Estimated PCD: 2023-05-31
Product
PI-2620
Clinical trial
Carvedilol vs.Metoprolol: A Comparison of Effects on Endothelial Function and Oxidative Stress in Response to Acute Hyperglycemia in Patients With Type 2 Diabetes and Hypertension
Status: Completed, Estimated PCD: 2008-06-01
Drug
Beta blockers
Clinical trial
Open-label, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Aripiprazole vs Paliperidone/Risperidone Using Multi-omics Data in Patients With a First Episode Psychosis
Status: Not yet recruiting, Estimated PCD: 2025-06-01
Product
Aripiprazole
Product
Paliperidone
Clinical trial
Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
Status: Completed, Estimated PCD: 2023-08-31
Product
Glyburide
Drug
Metformin
Clinical trial
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Status: Recruiting, Estimated PCD: 2025-12-31
Product
Midazolam + Dabigatran etexilate + Pitavastatin + Rosuvastatin + Atorvastatin
Clinical trial
Compassionate Use of Metreleptin in Previously-Treated Patients With Partial Lipodystrophy
Status: Active (not recruiting), Estimated PCD: 2025-07-31
Product
Metreleptin
Clinical trial
Making an "Obese"Brain(and Body)Lean: Insulin Detemir,Monoamines,and Reward
Status: Active (not recruiting), Estimated PCD: 2025-12-01
Product
Detemir
Clinical trial
Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy
Status: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (Close the GAP)
Status: Recruiting, Estimated PCD: 2025-10-31
Product
Sliding Scale Insulin
Product
Home Insulin
Product
Continuous Insulin Infusion
Clinical trial
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Status: Recruiting, Estimated PCD: 2024-12-30
Drug
Varlilumab
Drug
Dapagliflozin
Clinical trial
Outpatient Cervical Ripening and Labor Induction With Orally Administered Misoprostol for Term Pregnancies Complicated by Diabetes Mellitus
Status: Terminated, Estimated PCD: 2008-12-01
Product
Misoprostol
Clinical trial
Replication of Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (CANVAS Trial)
Status: Completed, Estimated PCD: 2021-02-18
Product
Canagliflozin
Product
DPP-4 inhibitor
Clinical trial
BARI-STEP:A Double-blinded, Randomised, Placebo-controlled Trial of Semaglutide 2.4 mg in Patients With Poor Weight-loss Following Bariatric Surgery.
Status: Active (not recruiting), Estimated PCD: 2025-09-01
Clinical trial
Durability of Early Initial Combination Therapy With Exenatide/Pioglitazone/Metformin vs Conventional Therapy in New Onset Type 2 Diabetes
Status: Completed, Estimated PCD: 2023-02-03
Product
metformin\pioglitazone\exenatide
Product
Metformin + Glyburide + Glargine
Clinical trial
A Pilot, Safety and Feasibility Trial of High-Dose Omega-3 Fatty Acids and High-Dose Cholecalciferol (Vitamin D) Supplementation in Type 1 Diabetes
Status: Active (not recruiting), Estimated PCD: 2025-09-01
Drug
Vitamin D3
Product
Omega-3
Clinical trial
Pharmacokinetics and Soft-Tissue Penetration of Tebipenem (SPR994) in Healthy Volunteer Subjects and Diabetic Patients With Lower Limb Infections
Status: Completed, Estimated PCD: 2022-08-30
Product
Tebipenem
Clinical trial
The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Transplantation in Aging-related Low-grade Inflammation Patients' Pro-inflammatory Cytokines: a Single-group, Open-label, Phase I/II Clinical Trial
Status: Active (not recruiting), Estimated PCD: 2026-01-01
Product
Umbilical Cord Mesenchymal Stem Cell
Clinical trial
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Status: , Estimated PCD: 2025-06-01
Product
Cephalexin
Product
Doxycycline
Product
Cefadroxil
Clinical trial
Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4
Status: Recruiting, Estimated PCD: 2024-12-01
Product
SGLT2 inhibitor
Clinical trial
Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease (FUTURE): a Multi-center, Double-blinded, Randomized, Placebo-controlled Trial
Status: Recruiting, Estimated PCD: 2023-12-31
Product
Dengzhanxixin
Clinical trial
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
Status: Recruiting, Estimated PCD: 2024-01-01
Product
Duragtide
Clinical trial
Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy
Status: Terminated, Estimated PCD: 2022-06-15
Clinical trial
Cystic Fibrosis - Insulin Deficiency, Early Action
Status: Completed, Estimated PCD: 2023-02-01
Clinical trial
Replication of the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Diabetes Trial in Healthcare Claims
Status: Completed, Estimated PCD: 2021-02-18
Clinical trial
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
Status: Completed, Estimated PCD: 2021-02-18
Product
Saxagliptin
Product
Sulfonylurea
Clinical trial
Replication of the TECOS Diabetes Trial in Healthcare Claims
Status: Completed, Estimated PCD: 2021-02-18
Drug
Sitagliptin
Clinical trial
A Randomized, Double-blind, Placebo Controlled Study (DANHEART): Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) and Metformin in Patients With Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT)
Status: Recruiting, Estimated PCD: 2026-12-31
Product
Hydralazine Isosorbide Dinitrate
Clinical trial
A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Not yet recruiting, Estimated PCD: 2025-06-30
Product
Chiglitazar
Clinical trial
Trial to Assess Chelation Therapy 2
Status: Completed, Estimated PCD: 2023-06-30
Product
disodium EDTA
Clinical trial
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
Status: Recruiting, Estimated PCD: 2028-10-31
Product
Dapagliflozin
Clinical trial
Carbohydrate Consumption as a Factor in Aspart Dosing Compared to the Regularly Used Standard of Care Basis of Dosing Aspart in the Inpatient Setting (CARB)
Status: Terminated, Estimated PCD: 2012-12-01
Product
aspart
Product
Aspart Insulin
Clinical trial
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer. Multicenter, Randomized, Double-blind, Placebo-controlled Study.
Status: Active (not recruiting), Estimated PCD: 2019-12-01
Product
Recombinant human Epidermal Growth Factor
Clinical trial
Effects on Re-endothelialisation With Bydureon Treatment Add on to Insulin Versus Insulin Alone, Both in Combination With Metformin in Type 2 Diabetic Subjects
Status: Completed, Estimated PCD: 2022-08-01
Product
Bydureon
Product
Humulin
Clinical trial
Randomized Cross-over Trial of Sodium Bicarbonate on Muscle Mitochondrial Energetics and Physical Endurance in Chronic Kidney Disease and Metabolic Acidosis
Status: Recruiting, Estimated PCD: 2025-12-31
Product
Sodium bicarbonate
Drug
placebo
Clinical trial
The Effect of Roxadustat on the Levels of Renal Oxygenation in Patients With Diabetes Nephropathy (FOXTROT)
Status: Not yet recruiting, Estimated PCD: 2025-01-01
Product
Roxadustat
Product
Darbepoietin Alfa
Clinical trial
The Role of Akkermansia Muciniphilia in Combating the Metabolic Effects of Androgen Deprivation Therapy in Men With Metastatic Prostate Cancer
Status: Not yet recruiting, Estimated PCD: 2025-06-01
Product
Apple Cider Vinegar
Clinical trial
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Status: Not yet recruiting, Estimated PCD: 2024-08-01
Product
Testosterone
Product
GnRH
Clinical trial
CROCODILE Study: Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
Status: Completed, Estimated PCD: 2022-05-15
Product
Aminohippurate Sodium
Product
Iohexol Inj
Clinical trial
Extending Time Without Diabetes After Bariatric Surgery: a Randomized Controlled Trial Comparing the Metformin Addition or Not to Standard Care
Status: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
Status: Recruiting, Estimated PCD: 2025-03-31
Product
Empagliflozin
Clinical trial
Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients in Terms of Mortality, Glycemic Control, and Cost Effectiveness - Prospective, Multicenter, Randomized Study
Status: Recruiting, Estimated PCD: 2029-09-01
Product
Optimized Medical Management
Clinical trial
Replication of the GRADE Diabetes Trial in Healthcare Claims Data
Status: Completed, Estimated PCD: 2021-08-01
Clinical trial
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Status: Completed, Estimated PCD: 2021-09-01
Clinical trial
Treating Insomnia and Improving Glycemic Control in Midlife Women With Insomnia and Pre-diabetes
Status: Recruiting, Estimated PCD: 2024-09-30
Product
Suvorexant
Clinical trial
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Status: Active (not recruiting), Estimated PCD: 2023-07-07
Clinical trial
Replication of the EMPA-REG OUTCOME Diabetes Trial in Healthcare Claims
Status: Completed, Estimated PCD: 2021-02-18
Clinical trial
Replication of the CARMELINA Diabetes Trial in Healthcare Claims
Status: Completed, Estimated PCD: 2021-02-18
Product
Linagliptin
Clinical trial
Replication of the LEADER Diabetes Trial in Healthcare Claims
Status: Completed, Estimated PCD: 2021-02-18
Clinical trial
The Effect of Lacosamide in Peripheral Neuropathic Pain: a Randomized, Double-blind, Placebo Controlled, Phenotype-stratified Study
Status: Terminated, Estimated PCD: 2022-06-03
Product
Lacosamide
Clinical trial
Dynamic Positron Emission Tomography Imaging With 11C-ER176 to Delineate Macrophage Activation in Diabetic Gastroparesis
Status: Completed, Estimated PCD: 2022-03-31
Product
PET/CT Scan with 11C-ER176
Clinical trial
The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Status: Completed, Estimated PCD: 2014-01-01
Product
Intransal Insulin
Clinical trial
Effect of Dapagliflozin at Discharge on Hospital Re-Admissions in Patients With Acutely Decompensated Heart Failure: A Randomized Controlled Study
Status: Completed, Estimated PCD: 2022-03-03
Clinical trial
Trial to Assess Chelation Therapy in Critical Limb Ischemia
Status: Recruiting, Estimated PCD: 2024-07-01
Product
Edetate Disodium
Clinical trial
Implementation of a Pragmatic Approach to Lower Diabetes Mellitus Risk After a Diagnosis of Gestational Diabetes Mellitus
Status: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Double Blind, Placebo Controlled, Cross Over Study to Investigate the Effectiveness and Safety of Eluxadoline in the Treatment of Diabetic Diarrhea
Status: Withdrawn, Estimated PCD: 2023-12-01
Product
Eluxadoline
Clinical trial
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Status: Recruiting, Estimated PCD: 2026-12-31
Product
Human Pancreatic Islet Transplantation
Clinical trial
A Study to Evaluate the Efficacy and Safety of Once-weekly Insulin Icodec When Switching From Daily Basal Insulins Compared to Once-daily Insulin Glargine U100 in Adults With Type 2 Diabetes
Status: Recruiting, Estimated PCD: 2025-05-16
Product
Insulin icodec
Product
Insulin glargine
Clinical trial
A Randomized, Double Blind, Phase I/II Trial of Low-Dose Interlekin-2 Immunotherapy in Established Type 1 Diabetes
Status: Withdrawn, Estimated PCD: 2026-12-01
Product
ILT-101
Clinical trial
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
Status: Not yet recruiting, Estimated PCD: 2026-12-31